全球生物可吸收支架市场规模、份额、趋势和成长分析报告（2026-2034年）

预计生物可吸收支架市场将从 2025 年的 4.7312 亿美元成长到 2034 年的 8.6035 亿美元，2026 年至 2034 年的复合年增长率为 6.87%。

随着医疗专业人员寻求治疗心血管疾病的先进方案，生物可吸收支架的全球市场正在不断扩大。生物可吸收支架是一种用于疏通阻塞动脉并随时间推移在体内逐渐溶解的医疗设备。与传统的金属支架不同，这些装置提供暂时的支撑，从而减少了与永久性植入相关的长期併发症。

多种因素正在推动生物可吸收支架市场的成长。心血管疾病的日益普遍以及对微创治疗方法需求的不断增长，正在促进创新支架技术的研发。生物可吸收支架在某些临床应用中极具吸引力，因为它们具有在支架溶解后恢復血管自然功能的优势。

随着心血管器械研究的不断深入，生物可吸收支架市场预计将持续成长。材料科学和支架设计的进步有望提升支架的安全性和有效性。随着医疗专业人员寻求治疗心臟病的先进方案，生物可吸收支架将在未来的心血管医学中发挥至关重要的作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球生物可吸收支架市场：依生物材料划分

• 市场分析、洞察与预测
• 生物可吸收聚合物支架
• 生物可吸收金属支架

第五章 全球生物可吸收支架市场：依应用划分

• 市场分析、洞察与预测
• 冠状动脉疾病
• 周边动脉疾病

第六章 全球生物可吸收支架市场：依吸收率划分

• 市场分析、洞察与预测
• 吸收速度慢
• 快速吸收率

第七章 全球生物可吸收支架市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 心臟中心
• 门诊手术中心

第八章 全球生物可吸收支架市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Amaranth Medical
  • Arterial Remodeling Technologies
  • Arterius Limited
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co. Ltd
  • MicroPort Scientific Corporation
  • Reva Medical
  • Terumo Corporation

The Bioabsorbable Stents Market size is expected to reach USD 860.35 Million in 2034 from USD 473.12 Million (2025) growing at a CAGR of 6.87% during 2026-2034.

The global bioabsorbable stents market has grown as healthcare providers explore advanced solutions for treating cardiovascular diseases. Bioabsorbable stents are medical devices used to open blocked arteries and gradually dissolve in the body over time. Unlike traditional metal stents, these devices provide temporary support and reduce long-term complications associated with permanent implants.

Several factors are driving the growth of the bioabsorbable stents market. Increasing prevalence of cardiovascular diseases and growing demand for minimally invasive treatment options have encouraged the development of innovative stent technologies. Bioabsorbable stents offer the advantage of restoring natural vessel function after the device dissolves, making them attractive in certain clinical applications.

Looking ahead, the bioabsorbable stents market is expected to expand as research in cardiovascular devices continues to advance. Improvements in material science and stent design may enhance safety and effectiveness. As healthcare providers seek advanced solutions for heart disease treatment, bioabsorbable stents may play an important role in future cardiovascular care.

MARKET SEGMENTATION

By Biomaterial

• Bioabsorbable Polymer-based Stents
• Bioabsorbable Metallic Stents

By Application

• Coronary Artery Disease
• Peripheral Artery Disease

By Absorption Rate

• Slow Absorption Rate
• Fast Absorption Rate

By End User

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers

COMPANIES PROFILED

• Amaranth Medical, Arterial Remodeling Technologies, Arterius Limited, B Braun Melsungen AG, Biotronik SE Co KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co Ltd, MicroPort Scientific Corporation, Reva Medical, Terumo Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOABSORBABLE STENTS MARKET: BY BIOMATERIAL 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Biomaterial
• 4.2. Bioabsorbable Polymer-based Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bioabsorbable Metallic Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOABSORBABLE STENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Coronary Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Peripheral Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOABSORBABLE STENTS MARKET: BY ABSORPTION RATE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Absorption Rate
• 6.2. Slow Absorption Rate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Fast Absorption Rate Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOABSORBABLE STENTS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOABSORBABLE STENTS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Biomaterial
  • 8.2.2 By Application
  • 8.2.3 By Absorption Rate
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Biomaterial
  • 8.3.2 By Application
  • 8.3.3 By Absorption Rate
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Biomaterial
  • 8.4.2 By Application
  • 8.4.3 By Absorption Rate
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Biomaterial
  • 8.5.2 By Application
  • 8.5.3 By Absorption Rate
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Biomaterial
  • 8.6.2 By Application
  • 8.6.3 By Absorption Rate
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOABSORBABLE STENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Amaranth Medical
  • 10.2.2 Arterial Remodeling Technologies
  • 10.2.3 Arterius Limited
  • 10.2.4 B. Braun Melsungen AG
  • 10.2.5 Biotronik SE & Co. KG
  • 10.2.6 Boston Scientific Corporation
  • 10.2.7 Elixir Medical Corporation
  • 10.2.8 Kyoto Medical Planning Co. Ltd
  • 10.2.9 MicroPort Scientific Corporation
  • 10.2.10 Reva Medical
  • 10.2.11 Terumo Corporation